Description of Blood Analysis:

Hepatitis Delta (HDV) is a “satellite” virus, meaning it is incomplete and can only infect individuals who are already carrying the Hepatitis B virus (HBV). It requires the surface antigen of Hepatitis B (HBsAg) to wrap itself in and replicate. The Anti-HDV test detects total antibodies (IgM and IgG) against this virus. Detecting these antibodies is critical because a “superinfection” of Delta on top of Chronic Hepatitis B is considered the most severe form of viral hepatitis, often leading to a much faster progression toward cirrhosis and liver failure than Hepatitis B alone.

What does the analysis represent?

• Goal: To determine if a patient has been exposed to or is currently infected with the Hepatitis Delta virus.
• Primary Application: Screening all HBsAg-positive patients for co-infection and investigating sudden clinical worsening in stable Hepatitis B patients.
• Method: Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA).

Recommendations for the Test (General)

• Time: Best performed during morning hours.
• Fasting: 8–12 hours of fasting is recommended for optimal serum clarity.
• Rest: Avoid physical exertion and smoking for 30 minutes before the blood draw.
• Specific Rules: This test is only clinically relevant for individuals who are HBsAg-positive (Hepatitis B carriers).

What can affect the results?

• Factors Altering Levels: The “window period” (testing too soon after exposure); severe immunosuppression which may delay antibody production; or technical cross-reactivity with other immunological factors.

When to take the test?

• Recommendations: Every person diagnosed with Hepatitis B should be screened for Delta at least once. It is also urgent if a Hepatitis B patient experiences a sudden “flare” (spike in liver enzymes).
• Preparation: Follow standard fasting protocols; no other special preparation is needed.

How to interpret the results?

The evaluation of your Anti-HDV status must be conducted exclusively by a Hepatologist or Infectious Disease Specialist. A positive (reactive) result indicates exposure but does not distinguish between a past resolved infection and a current active one. Furthermore, because HDV is so aggressive, a doctor must correlate this result with your “viral load” and liver scans. Only a professional can determine if the Delta virus is the primary driver of liver damage in your specific case and design a treatment plan accordingly.

Possible further investigations

• HDV RNA (PCR): The essential next step to see if the virus is actually replicating in the blood.
• HBV DNA (Quantitative): To see how the two viruses are interacting (often one suppresses the other).
• Liver Function Panel (ALT/AST): To measure current liver inflammation.
• FibroScan: To check for advanced scarring or cirrhosis.
• Consultation with a Specialist: To discuss specialized treatments like interferon-based therapies.

When does the next step make sense?

If the antibody result is positive, the immediate next step is to perform an HDV RNA PCR test. This is the only way to confirm if the infection is active and requires treatment. Because HDV significantly increases the risk of liver complications, all follow-up steps should be managed closely by your healthcare provider.

👉 If necessary, you can discuss the results of the analysis with a specialist, such as an gastroenterologist (Doctors – TAMC).